American Century Companies Inc. Takes Position in Grail, Inc. (NASDAQ:GRAL)

American Century Companies Inc. acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 11,990 shares of the company's stock, valued at approximately $214,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Grail during the fourth quarter valued at approximately $244,000. Moloney Securities Asset Management LLC acquired a new stake in Grail during the 4th quarter valued at approximately $559,000. Rhumbline Advisers acquired a new stake in Grail in the fourth quarter valued at $456,000. Wesbanco Bank Inc. bought a new position in shares of Grail during the fourth quarter worth about $523,000. Finally, Slow Capital Inc. acquired a new position in shares of Grail in the 4th quarter worth approximately $2,379,000.

Grail Price Performance

Shares of NASDAQ:GRAL opened at $24.85 on Tuesday. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The company's fifty day moving average is $33.33 and its two-hundred day moving average is $23.34.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. On average, equities research analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This represents a 0.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock worth $360,436.

Wall Street Analyst Weigh In

Separately, Morgan Stanley increased their price target on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Remove Ads

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.